CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with or without bevacizumab (B) as first-line therapy for locally recurrent or metastatic breast cancer (MBC) Meeting Abstract
| Authors: | Rugo, H. S.; Barry, W. T.; Moreno-Aspitia, A.; Lyss, A. P.; Cirrincione, C.; Mayer, E. L.; Naughton, M.; Layman, R. M.; Carey, L. A.; Somer, R. A.; Perez, E. A.; Hudis, C.; Winer, E. P. |
| Abstract Title: | CALGB 40502/NCCTG N063H: Randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-paclitaxel (NP) or ixabepilone (Ix) with or without bevacizumab (B) as first-line therapy for locally recurrent or metastatic breast cancer (MBC) |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-06-20 |
| Language: | English |
| ACCESSION: | WOS:000318026200005 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.18_suppl.cra1002 |
| Notes: | Meeting Abstract: CRA1002 -- Source: Wos |
